Global C-X-C Chemokine Receptor Type 4 Market Growth (Status and Outlook) 2022-2028
- LP 4929109
- 110 Pages
- March 2022
- Pharmaceuticals
The United States C-X-C Chemokine Receptor Type 4 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global C-X-C Chemokine Receptor Type 4 market, reaching US$ million by the year 2028. As for the Europe C-X-C Chemokine Receptor Type 4 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main C-X-C Chemokine Receptor Type 4 players cover AdAlta Pty Ltd., Ambrx, Inc., Anchor Therapeutics, Inc., and Biokine Therapeutics Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of C-X-C Chemokine Receptor Type 4 market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
AM-3114
BL-8040
GMI-1359
HPH-112
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Liver Cancer
Myocardial Infarction
Renal Cell Carcinoma
Stroke
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AdAlta Pty Ltd.
Ambrx, Inc.
Anchor Therapeutics, Inc.
Biokine Therapeutics Ltd.
BioLineRx, Ltd.
Bristol-Myers Squibb Company
Eli Lilly and Company
Globavir Biosciences, Inc.
GlycoMimetics, Inc.
NeED Pharma s.r.l.
Pharis Biotec GmbH
Polyphor Ltd.
Sanofi
TaiGen Biotechnology Co., Ltd.
Upsher-Smith Laboratories, Inc.
X4 Pharmaceuticals, Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global C-X-C Chemokine Receptor Type 4 Market Size 2017-2028
2.1.2 C-X-C Chemokine Receptor Type 4 Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 C-X-C Chemokine Receptor Type 4 Segment by Type
2.2.1 AM-3114
2.2.2 BL-8040
2.2.3 GMI-1359
2.2.4 HPH-112
2.2.5 Others
2.3 C-X-C Chemokine Receptor Type 4 Market Size by Type
2.3.1 C-X-C Chemokine Receptor Type 4 Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global C-X-C Chemokine Receptor Type 4 Market Size Market Share by Type (2017-2022)
2.4 C-X-C Chemokine Receptor Type 4 Segment by Application
2.4.1 Liver Cancer
2.4.2 Myocardial Infarction
2.4.3 Renal Cell Carcinoma
2.4.4 Stroke
2.4.5 Others
2.5 C-X-C Chemokine Receptor Type 4 Market Size by Application
2.5.1 C-X-C Chemokine Receptor Type 4 Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global C-X-C Chemokine Receptor Type 4 Market Size Market Share by Application (2017-2022)
3 C-X-C Chemokine Receptor Type 4 Market Size by Player
3.1 C-X-C Chemokine Receptor Type 4 Market Size Market Share by Players
3.1.1 Global C-X-C Chemokine Receptor Type 4 Revenue by Players (2020-2022)
3.1.2 Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Players (2020-2022)
3.2 Global C-X-C Chemokine Receptor Type 4 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 C-X-C Chemokine Receptor Type 4 by Regions
4.1 C-X-C Chemokine Receptor Type 4 Market Size by Regions (2017-2022)
4.2 Americas C-X-C Chemokine Receptor Type 4 Market Size Growth (2017-2022)
4.3 APAC C-X-C Chemokine Receptor Type 4 Market Size Growth (2017-2022)
4.4 Europe C-X-C Chemokine Receptor Type 4 Market Size Growth (2017-2022)
4.5 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Growth (2017-2022)
5 Americas
5.1 Americas C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022)
5.2 Americas C-X-C Chemokine Receptor Type 4 Market Size by Type (2017-2022)
5.3 Americas C-X-C Chemokine Receptor Type 4 Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC C-X-C Chemokine Receptor Type 4 Market Size by Region (2017-2022)
6.2 APAC C-X-C Chemokine Receptor Type 4 Market Size by Type (2017-2022)
6.3 APAC C-X-C Chemokine Receptor Type 4 Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe C-X-C Chemokine Receptor Type 4 by Country (2017-2022)
7.2 Europe C-X-C Chemokine Receptor Type 4 Market Size by Type (2017-2022)
7.3 Europe C-X-C Chemokine Receptor Type 4 Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa C-X-C Chemokine Receptor Type 4 by Region (2017-2022)
8.2 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Type (2017-2022)
8.3 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global C-X-C Chemokine Receptor Type 4 Market Forecast
10.1 Global C-X-C Chemokine Receptor Type 4 Forecast by Regions (2023-2028)
10.1.1 Global C-X-C Chemokine Receptor Type 4 Forecast by Regions (2023-2028)
10.1.2 Americas C-X-C Chemokine Receptor Type 4 Forecast
10.1.3 APAC C-X-C Chemokine Receptor Type 4 Forecast
10.1.4 Europe C-X-C Chemokine Receptor Type 4 Forecast
10.1.5 Middle East & Africa C-X-C Chemokine Receptor Type 4 Forecast
10.2 Americas C-X-C Chemokine Receptor Type 4 Forecast by Country (2023-2028)
10.2.1 United States C-X-C Chemokine Receptor Type 4 Market Forecast
10.2.2 Canada C-X-C Chemokine Receptor Type 4 Market Forecast
10.2.3 Mexico C-X-C Chemokine Receptor Type 4 Market Forecast
10.2.4 Brazil C-X-C Chemokine Receptor Type 4 Market Forecast
10.3 APAC C-X-C Chemokine Receptor Type 4 Forecast by Region (2023-2028)
10.3.1 China C-X-C Chemokine Receptor Type 4 Market Forecast
10.3.2 Japan C-X-C Chemokine Receptor Type 4 Market Forecast
10.3.3 Korea C-X-C Chemokine Receptor Type 4 Market Forecast
10.3.4 Southeast Asia C-X-C Chemokine Receptor Type 4 Market Forecast
10.3.5 India C-X-C Chemokine Receptor Type 4 Market Forecast
10.3.6 Australia C-X-C Chemokine Receptor Type 4 Market Forecast
10.4 Europe C-X-C Chemokine Receptor Type 4 Forecast by Country (2023-2028)
10.4.1 Germany C-X-C Chemokine Receptor Type 4 Market Forecast
10.4.2 France C-X-C Chemokine Receptor Type 4 Market Forecast
10.4.3 UK C-X-C Chemokine Receptor Type 4 Market Forecast
10.4.4 Italy C-X-C Chemokine Receptor Type 4 Market Forecast
10.4.5 Russia C-X-C Chemokine Receptor Type 4 Market Forecast
10.5 Middle East & Africa C-X-C Chemokine Receptor Type 4 Forecast by Region (2023-2028)
10.5.1 Egypt C-X-C Chemokine Receptor Type 4 Market Forecast
10.5.2 South Africa C-X-C Chemokine Receptor Type 4 Market Forecast
10.5.3 Israel C-X-C Chemokine Receptor Type 4 Market Forecast
10.5.4 Turkey C-X-C Chemokine Receptor Type 4 Market Forecast
10.5.5 GCC Countries C-X-C Chemokine Receptor Type 4 Market Forecast
10.6 Global C-X-C Chemokine Receptor Type 4 Forecast by Type (2023-2028)
10.7 Global C-X-C Chemokine Receptor Type 4 Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AdAlta Pty Ltd.
11.1.1 AdAlta Pty Ltd. Company Information
11.1.2 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Product Offered
11.1.3 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AdAlta Pty Ltd. Main Business Overview
11.1.5 AdAlta Pty Ltd. Latest Developments
11.2 Ambrx, Inc.
11.2.1 Ambrx, Inc. Company Information
11.2.2 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
11.2.3 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Ambrx, Inc. Main Business Overview
11.2.5 Ambrx, Inc. Latest Developments
11.3 Anchor Therapeutics, Inc.
11.3.1 Anchor Therapeutics, Inc. Company Information
11.3.2 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
11.3.3 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Anchor Therapeutics, Inc. Main Business Overview
11.3.5 Anchor Therapeutics, Inc. Latest Developments
11.4 Biokine Therapeutics Ltd.
11.4.1 Biokine Therapeutics Ltd. Company Information
11.4.2 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Product Offered
11.4.3 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Biokine Therapeutics Ltd. Main Business Overview
11.4.5 Biokine Therapeutics Ltd. Latest Developments
11.5 BioLineRx, Ltd.
11.5.1 BioLineRx, Ltd. Company Information
11.5.2 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Product Offered
11.5.3 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 BioLineRx, Ltd. Main Business Overview
11.5.5 BioLineRx, Ltd. Latest Developments
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Information
11.6.2 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Product Offered
11.6.3 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bristol-Myers Squibb Company Main Business Overview
11.6.5 Bristol-Myers Squibb Company Latest Developments
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Information
11.7.2 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Product Offered
11.7.3 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Eli Lilly and Company Main Business Overview
11.7.5 Eli Lilly and Company Latest Developments
11.8 Globavir Biosciences, Inc.
11.8.1 Globavir Biosciences, Inc. Company Information
11.8.2 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
11.8.3 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Globavir Biosciences, Inc. Main Business Overview
11.8.5 Globavir Biosciences, Inc. Latest Developments
11.9 GlycoMimetics, Inc.
11.9.1 GlycoMimetics, Inc. Company Information
11.9.2 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
11.9.3 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 GlycoMimetics, Inc. Main Business Overview
11.9.5 GlycoMimetics, Inc. Latest Developments
11.10 NeED Pharma s.r.l.
11.10.1 NeED Pharma s.r.l. Company Information
11.10.2 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Product Offered
11.10.3 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 NeED Pharma s.r.l. Main Business Overview
11.10.5 NeED Pharma s.r.l. Latest Developments
11.11 Pharis Biotec GmbH
11.11.1 Pharis Biotec GmbH Company Information
11.11.2 Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Product Offered
11.11.3 Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Pharis Biotec GmbH Main Business Overview
11.11.5 Pharis Biotec GmbH Latest Developments
11.12 Polyphor Ltd.
11.12.1 Polyphor Ltd. Company Information
11.12.2 Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Product Offered
11.12.3 Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Polyphor Ltd. Main Business Overview
11.12.5 Polyphor Ltd. Latest Developments
11.13 Sanofi
11.13.1 Sanofi Company Information
11.13.2 Sanofi C-X-C Chemokine Receptor Type 4 Product Offered
11.13.3 Sanofi C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Sanofi Main Business Overview
11.13.5 Sanofi Latest Developments
11.14 TaiGen Biotechnology Co., Ltd.
11.14.1 TaiGen Biotechnology Co., Ltd. Company Information
11.14.2 TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Product Offered
11.14.3 TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 TaiGen Biotechnology Co., Ltd. Main Business Overview
11.14.5 TaiGen Biotechnology Co., Ltd. Latest Developments
11.15 Upsher-Smith Laboratories, Inc.
11.15.1 Upsher-Smith Laboratories, Inc. Company Information
11.15.2 Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
11.15.3 Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Upsher-Smith Laboratories, Inc. Main Business Overview
11.15.5 Upsher-Smith Laboratories, Inc. Latest Developments
11.16 X4 Pharmaceuticals, Inc.
11.16.1 X4 Pharmaceuticals, Inc. Company Information
11.16.2 X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
11.16.3 X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 X4 Pharmaceuticals, Inc. Main Business Overview
11.16.5 X4 Pharmaceuticals, Inc. Latest Developments
12 Research Findings and Conclusion
Table 1. C-X-C Chemokine Receptor Type 4 Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of AM-3114
Table 3. Major Players of BL-8040
Table 4. Major Players of GMI-1359
Table 5. Major Players of HPH-112
Table 6. Major Players of Others
Table 7. C-X-C Chemokine Receptor Type 4 Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global C-X-C Chemokine Receptor Type 4 Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global C-X-C Chemokine Receptor Type 4 Market Size Market Share by Type (2017-2022)
Table 10. C-X-C Chemokine Receptor Type 4 Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global C-X-C Chemokine Receptor Type 4 Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global C-X-C Chemokine Receptor Type 4 Market Size Market Share by Application (2017-2022)
Table 13. Global C-X-C Chemokine Receptor Type 4 Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Player (2020-2022)
Table 15. C-X-C Chemokine Receptor Type 4 Key Players Head office and Products Offered
Table 16. C-X-C Chemokine Receptor Type 4 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global C-X-C Chemokine Receptor Type 4 Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global C-X-C Chemokine Receptor Type 4 Market Size Market Share by Regions (2017-2022)
Table 21. Americas C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas C-X-C Chemokine Receptor Type 4 Market Size Market Share by Country (2017-2022)
Table 23. Americas C-X-C Chemokine Receptor Type 4 Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas C-X-C Chemokine Receptor Type 4 Market Size Market Share by Type (2017-2022)
Table 25. Americas C-X-C Chemokine Receptor Type 4 Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas C-X-C Chemokine Receptor Type 4 Market Size Market Share by Application (2017-2022)
Table 27. APAC C-X-C Chemokine Receptor Type 4 Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC C-X-C Chemokine Receptor Type 4 Market Size Market Share by Region (2017-2022)
Table 29. APAC C-X-C Chemokine Receptor Type 4 Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC C-X-C Chemokine Receptor Type 4 Market Size Market Share by Type (2017-2022)
Table 31. APAC C-X-C Chemokine Receptor Type 4 Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC C-X-C Chemokine Receptor Type 4 Market Size Market Share by Application (2017-2022)
Table 33. Europe C-X-C Chemokine Receptor Type 4 Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe C-X-C Chemokine Receptor Type 4 Market Size Market Share by Country (2017-2022)
Table 35. Europe C-X-C Chemokine Receptor Type 4 Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe C-X-C Chemokine Receptor Type 4 Market Size Market Share by Type (2017-2022)
Table 37. Europe C-X-C Chemokine Receptor Type 4 Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe C-X-C Chemokine Receptor Type 4 Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of C-X-C Chemokine Receptor Type 4
Table 46. Key Market Challenges & Risks of C-X-C Chemokine Receptor Type 4
Table 47. Key Industry Trends of C-X-C Chemokine Receptor Type 4
Table 48. Global C-X-C Chemokine Receptor Type 4 Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global C-X-C Chemokine Receptor Type 4 Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global C-X-C Chemokine Receptor Type 4 Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global C-X-C Chemokine Receptor Type 4 Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global C-X-C Chemokine Receptor Type 4 Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global C-X-C Chemokine Receptor Type 4 Market Size Market Share Forecast by Application (2023-2028)
Table 54. AdAlta Pty Ltd. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 55. AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Product Offered
Table 56. AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. AdAlta Pty Ltd. Main Business
Table 58. AdAlta Pty Ltd. Latest Developments
Table 59. Ambrx, Inc. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 60. Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
Table 61. Ambrx, Inc. Main Business
Table 62. Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Ambrx, Inc. Latest Developments
Table 64. Anchor Therapeutics, Inc. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 65. Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
Table 66. Anchor Therapeutics, Inc. Main Business
Table 67. Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Anchor Therapeutics, Inc. Latest Developments
Table 69. Biokine Therapeutics Ltd. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 70. Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Product Offered
Table 71. Biokine Therapeutics Ltd. Main Business
Table 72. Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Biokine Therapeutics Ltd. Latest Developments
Table 74. BioLineRx, Ltd. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 75. BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Product Offered
Table 76. BioLineRx, Ltd. Main Business
Table 77. BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. BioLineRx, Ltd. Latest Developments
Table 79. Bristol-Myers Squibb Company Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 80. Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Product Offered
Table 81. Bristol-Myers Squibb Company Main Business
Table 82. Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Bristol-Myers Squibb Company Latest Developments
Table 84. Eli Lilly and Company Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 85. Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Product Offered
Table 86. Eli Lilly and Company Main Business
Table 87. Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Eli Lilly and Company Latest Developments
Table 89. Globavir Biosciences, Inc. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 90. Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
Table 91. Globavir Biosciences, Inc. Main Business
Table 92. Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Globavir Biosciences, Inc. Latest Developments
Table 94. GlycoMimetics, Inc. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 95. GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
Table 96. GlycoMimetics, Inc. Main Business
Table 97. GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. GlycoMimetics, Inc. Latest Developments
Table 99. NeED Pharma s.r.l. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 100. NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Product Offered
Table 101. NeED Pharma s.r.l. Main Business
Table 102. NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. NeED Pharma s.r.l. Latest Developments
Table 104. Pharis Biotec GmbH Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 105. Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Product Offered
Table 106. Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. Pharis Biotec GmbH Main Business
Table 108. Pharis Biotec GmbH Latest Developments
Table 109. Polyphor Ltd. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 110. Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Product Offered
Table 111. Polyphor Ltd. Main Business
Table 112. Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Polyphor Ltd. Latest Developments
Table 114. Sanofi Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 115. Sanofi C-X-C Chemokine Receptor Type 4 Product Offered
Table 116. Sanofi Main Business
Table 117. Sanofi C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Sanofi Latest Developments
Table 119. TaiGen Biotechnology Co., Ltd. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 120. TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Product Offered
Table 121. TaiGen Biotechnology Co., Ltd. Main Business
Table 122. TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. TaiGen Biotechnology Co., Ltd. Latest Developments
Table 124. Upsher-Smith Laboratories, Inc. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 125. Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
Table 126. Upsher-Smith Laboratories, Inc. Main Business
Table 127. Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Upsher-Smith Laboratories, Inc. Latest Developments
Table 129. X4 Pharmaceuticals, Inc. Details, Company Type, C-X-C Chemokine Receptor Type 4 Area Served and Its Competitors
Table 130. X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Product Offered
Table 131. X4 Pharmaceuticals, Inc. Main Business
Table 132. X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. X4 Pharmaceuticals, Inc. Latest Developments
List of Figures
Figure 1. C-X-C Chemokine Receptor Type 4 Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global C-X-C Chemokine Receptor Type 4 Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global C-X-C Chemokine Receptor Type 4 Market Size Market Share by Type in 2021
Figure 7. C-X-C Chemokine Receptor Type 4 in Liver Cancer
Figure 8. Global C-X-C Chemokine Receptor Type 4 Market: Liver Cancer (2017-2022) & ($ Millions)
Figure 9. C-X-C Chemokine Receptor Type 4 in Myocardial Infarction
Figure 10. Global C-X-C Chemokine Receptor Type 4 Market: Myocardial Infarction (2017-2022) & ($ Millions)
Figure 11. C-X-C Chemokine Receptor Type 4 in Renal Cell Carcinoma
Figure 12. Global C-X-C Chemokine Receptor Type 4 Market: Renal Cell Carcinoma (2017-2022) & ($ Millions)
Figure 13. C-X-C Chemokine Receptor Type 4 in Stroke
Figure 14. Global C-X-C Chemokine Receptor Type 4 Market: Stroke (2017-2022) & ($ Millions)
Figure 15. C-X-C Chemokine Receptor Type 4 in Others
Figure 16. Global C-X-C Chemokine Receptor Type 4 Market: Others (2017-2022) & ($ Millions)
Figure 17. Global C-X-C Chemokine Receptor Type 4 Market Size Market Share by Application in 2021
Figure 18. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Player in 2021
Figure 19. Global C-X-C Chemokine Receptor Type 4 Market Size Market Share by Regions (2017-2022)
Figure 20. Americas C-X-C Chemokine Receptor Type 4 Market Size 2017-2022 ($ Millions)
Figure 21. APAC C-X-C Chemokine Receptor Type 4 Market Size 2017-2022 ($ Millions)
Figure 22. Europe C-X-C Chemokine Receptor Type 4 Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size 2017-2022 ($ Millions)
Figure 24. Americas C-X-C Chemokine Receptor Type 4 Value Market Share by Country in 2021
Figure 25. Americas C-X-C Chemokine Receptor Type 4 Consumption Market Share by Type in 2021
Figure 26. Americas C-X-C Chemokine Receptor Type 4 Market Size Market Share by Application in 2021
Figure 27. United States C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC C-X-C Chemokine Receptor Type 4 Market Size Market Share by Region in 2021
Figure 32. APAC C-X-C Chemokine Receptor Type 4 Market Size Market Share by Application in 2021
Figure 33. China C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 37. India C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe C-X-C Chemokine Receptor Type 4 Market Size Market Share by Country in 2021
Figure 40. Europe C-X-C Chemokine Receptor Type 4 Market Size Market Share by Type in 2021
Figure 41. Europe C-X-C Chemokine Receptor Type 4 Market Size Market Share by Application in 2021
Figure 42. Germany C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 43. France C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Market Share by Application in 2021
Figure 50. Egypt C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country C-X-C Chemokine Receptor Type 4 Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 56. APAC C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 57. Europe C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 59. United States C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 60. Canada C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 61. Mexico C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 62. Brazil C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 63. China C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 64. Japan C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 65. Korea C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 67. India C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 68. Australia C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 69. Germany C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 70. France C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 71. UK C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 72. Italy C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 73. Russia C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 74. Spain C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 75. Egypt C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 76. South Africa C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 77. Israel C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 78. Turkey C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries C-X-C Chemokine Receptor Type 4 Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
